Health Canada Approves Supplement with Immune-Health Epicor Ingredient
Products containing 500 mg of Epicor can now bear this claim in the Canadian market: “Helps reduce incidence of cold and flu symptoms.”
Health Canada has approved for sale in the Canadian market a natural health product containing immune-health ingredient EpiCor. Before natural health products can be sold in Canada, they must first undergo premarket approval for safety, efficacy, and quality. Approved products are given a Natural Product Number (NPN) or a Homeophatic Medicine Number (DIN-HM).
Embria Health Sciences (Ankeny, IA), EpiCor’s maker, says Health Canada’s decision was based on a number of scientific studies showing that EpiCor provides benefits, without safety concerns. The company points out that the Canadian approval is especially notable considering that EpiCor’s research was reviewed using pharmaceutical guidelines-and the fact that no disclaimers are being required to limit benefits to certain populations.
Additionally, EpiCor was given an approved health claim. Products containing 500 mg of Epicor can now bear this claim in the Canadian market: “Helps reduce incidence of cold and flu symptoms.”
Embria says EpciCor offers clear benefits without safety concerns caused by other ingredients currently available. “We believe that the cold and flu market in Canada needed something new and innovative, and EpiCor delivers that with very few warnings and cautions that are found on other products,” says Alex Azoulay, president of contract manufacturer Praxis Nutri-Pharma (Chateauguay, QC, Canada), which made the announcement together with Embria. Praxis Nutri-Pharma produces the EpiCor product that was approved. “Now we can offer EpiCor to new or existing customers.”
“This is a significant accomplishment for EpiCor since Health Canada’s process for confirming health claims is perhaps one of the most comprehensive in the world,” adds Paul Faganel, Embria’s president. “Recently, we’ve seen other immune products have issues with U.S. regulators, and we are very pleased Health Canada confirmed EpiCor’s research is second to none by allowing the Praxis product to use such strong claims.”
EpiCor also has a new dietary supplements (NDI) on file with FDA in the United States.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
